- Home
- Publications
- Publication Search
- Publication Details
Title
The gut microbiome-bile acid axis in hepatocarcinogenesis
Authors
Keywords
Gut microbiome, Bile acids, Hepatocellular carcinoma
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 133, Issue -, Pages 111036
Publisher
Elsevier BV
Online
2020-11-29
DOI
10.1016/j.biopha.2020.111036
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TGR5 promotes cholangiocarcinoma by interacting with mortalin
- (2020) Ai-Di Li et al. EXPERIMENTAL CELL RESEARCH
- Detection of circulating tumor cells and their implications as a novel biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma
- (2020) Joseph C Ahn et al. HEPATOLOGY
- Treatment of hepatocellular carcinoma in the Precision Medicine era: from treatment stage migration to therapeutic hierarchy
- (2020) Alessandro Vitale et al. HEPATOLOGY
- Gut microbiome in HCC – Mechanisms, diagnosis and therapy
- (2020) Robert F. Schwabe et al. JOURNAL OF HEPATOLOGY
- The significance of exosomes in the development and treatment of hepatocellular carcinoma
- (2020) Xin Li et al. Molecular Cancer
- Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota–bile acid–farnesoid X receptor axis
- (2020) Hongshan Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Dominant gut Prevotella copri in gastrectomised non-obese diabetic Goto–Kakizaki rats improves glucose homeostasis through enhanced FXR signalling
- (2020) Noémie Péan et al. DIABETOLOGIA
- Capsaicin improves glucose homeostasis by enhancing glucagon‐like peptide‐1 secretion through the regulation of bile acid metabolism via the remodeling of the gut microbiota in male mice
- (2020) Suocheng Hui et al. FASEB JOURNAL
- Vancomycin prevents fermentable fiber-induced liver cancer in mice with dysbiotic gut microbiota
- (2020) Vishal Singh et al. Gut Microbes
- Potential role of gut microbiota, the proto-oncogene PIKE (Agap2) and cytochrome P450 CYP2W1 in promotion of liver cancer by alcoholic and nonalcoholic fatty liver disease and protection by dietary soy protein
- (2020) Martin J. Ronis et al. CHEMICO-BIOLOGICAL INTERACTIONS
- The Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Pan-Cancer
- (2020) Runzhi Huang et al. PPAR Research
- Bacterial translocation and risk of liver cancer in a Finnish cohort
- (2019) Baiyu Yang et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Contribution of the gut microbiota to the regulation of host metabolism and energy balance: a focus on the gut–liver axis
- (2019) N. M. Delzenne et al. PROCEEDINGS OF THE NUTRITION SOCIETY
- Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma
- (2019) Qisha Liu et al. Gut Pathogens
- TGR5-dependent hepatoprotection through the regulation of biliary epithelium barrier function
- (2019) Grégory Merlen et al. GUT
- A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma
- (2019) Federico Piñero et al. Annals of Hepatology
- PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma
- (2019) Jiao Feng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Circulating Microbiota-Based Metagenomic Signature for Detection of Hepatocellular Carcinoma
- (2019) Eun Ju Cho et al. Scientific Reports
- Analysis of the Relationship Between the Degree of Dysbiosis in Gut Microbiota and Prognosis at Different Stages of Primary Hepatocellular Carcinoma
- (2019) Jiajia Ni et al. Frontiers in Microbiology
- Quercetin shows anti‐tumor effect in hepatocellular carcinoma LM3 cells by abrogating JAK2/STAT3 signaling pathway
- (2019) Liwei Wu et al. Cancer Medicine
- Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma
- (2019) Yi Zheng et al. Journal for ImmunoTherapy of Cancer
- Capsaicin Improves Glucose Tolerance and Insulin Sensitivity Through Modulation of the Gut Microbiota‐Bile Acid‐FXR Axis in Type 2 Diabetic db/db Mice
- (2019) Suocheng Hui et al. MOLECULAR NUTRITION & FOOD RESEARCH
- A global view of hepatocellular carcinoma: trends, risk, prevention and management
- (2019) Ju Dong Yang et al. Nature Reviews Gastroenterology & Hepatology
- Zn(II)-curcumin solid dispersion impairs hepatocellular carcinoma growth and enhances chemotherapy by modulating gut microbiota-mediated zinc homeostasis
- (2019) Rihui Wu et al. PHARMACOLOGICAL RESEARCH
- Promotion and induction of liver cancer by gut microbiome-mediated modulation of bile acids
- (2019) Baolei Jia et al. PLoS Pathogens
- Smoking as an Independent Risk Factor for Hepatocellular Carcinoma Due to the α7-Nachr Modulating the JAK2/STAT3 Signaling Axis
- (2019) Li et al. Journal of Clinical Medicine
- Bile acids in glucose metabolism and insulin signalling — mechanisms and research needs
- (2019) Tiara R. Ahmad et al. Nature Reviews Endocrinology
- Diversification of host bile acids by members of the gut microbiota
- (2019) Jenessa A. Winston et al. Gut Microbes
- Current strategies for the treatment of intermediate and advanced hepatocellular carcinoma
- (2019) Arndt Vogel et al. CANCER TREATMENT REVIEWS
- OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism
- (2019) W.Q. Dai et al. JOURNAL OF HEPATOLOGY
- The membrane bile acid receptor TGR5 drives cell growth and migration via activation of the JAK2/STAT3 signaling pathway in non-small cell lung cancer
- (2018) Xueqing Liu et al. CANCER LETTERS
- Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in db/db Mice
- (2018) Eleni Beli et al. DIABETES
- Bile Acid Metabolism in Liver Pathobiology
- (2018) John Y. L. Chiang et al. GENE EXPRESSION
- Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease
- (2018) Francesca Romana Ponziani et al. HEPATOLOGY
- Farnesoid X Receptor Activation Enhances Transforming Growth Factor β-Induced Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells
- (2018) Masahiko Kainuma et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effects of the gut–liver axis on ischaemia-mediated hepatocellular carcinoma recurrence in the mouse liver
- (2018) Lorenzo A. Orci et al. JOURNAL OF HEPATOLOGY
- The gut–liver axis and the intersection with the microbiome
- (2018) Anupriya Tripathi et al. Nature Reviews Gastroenterology & Hepatology
- Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
- (2018) Chi Ma et al. SCIENCE
- Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice
- (2018) Shoji Yamada et al. Oncotarget
- Different Sex-Based Responses of Gut Microbiota During the Development of Hepatocellular Carcinoma in Liver-Specific Tsc1-Knockout Mice
- (2018) Rong Huang et al. Frontiers in Microbiology
- Dysregulation of BSEP and MRP2 May Play an Important Role in Isoniazid-Induced Liver Injury via the SIRT1/FXR Pathway in Rats and HepG2 Cells
- (2018) Xiaoyu Qu et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Bile acid homeostasis paradigm and its connotation with cholestatic liver diseases
- (2018) Tingting Yang et al. DRUG DISCOVERY TODAY
- Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma
- (2018) Zhigang Ren et al. GUT
- Dietary Tomato Powder Inhibits High-Fat Diet–Promoted Hepatocellular Carcinoma with Alteration of Gut Microbiota in Mice Lacking Carotenoid Cleavage Enzymes
- (2018) Hui Xia et al. Cancer Prevention Research
- Trimethylamine N-oxide, a gut microbiota-dependent metabolite of choline, is positively associated with the risk of primary liver cancer: a case-control study
- (2018) Zhao-Yan Liu et al. Nutrition & Metabolism
- Role of TGR5 (GPBAR1) in Liver Disease
- (2018) Dieter Häussinger et al. SEMINARS IN LIVER DISEASE
- Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation
- (2017) Lili Sheng et al. JOURNAL OF PATHOLOGY
- Mechanisms of bile acid mediated inflammation in the liver
- (2017) Man Li et al. MOLECULAR ASPECTS OF MEDICINE
- Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity
- (2017) Shabnam Shalapour et al. NATURE
- The gut microbiome and liver cancer: mechanisms and clinical translation
- (2017) Le-Xing Yu et al. Nature Reviews Gastroenterology & Hepatology
- Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
- (2017) Wei Jia et al. Nature Reviews Gastroenterology & Hepatology
- Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE 2 -Mediated Suppression of Antitumor Immunity
- (2017) Tze Mun Loo et al. Cancer Discovery
- Lithocholic bile acid inhibits lipogenesis and induces apoptosis in breast cancer cells
- (2017) Trang H. Luu et al. CELLULAR ONCOLOGY
- Rethinking the bile acid/gut microbiome axis in cancer
- (2017) John P. Phelan et al. Oncotarget
- The G-protein-coupled bile acid receptor Gpbar1 (TGR5) protects against renal inflammation and renal cancer cell proliferation and migration through antagonizing NF-κB and STAT3 signaling pathways
- (2017) Jia Su et al. Oncotarget
- Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
- (2016) Annika Wahlström et al. Cell Metabolism
- Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome
- (2016) Chuansheng Guo et al. IMMUNITY
- Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob mice
- (2016) M.-Y. Park et al. JOURNAL OF APPLIED MICROBIOLOGY
- Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice
- (2016) Jun Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Profile of Gut Microbiota Associated With the Presence of Hepatocellular Cancer in Patients With Liver Cirrhosis
- (2016) M. Grąt et al. TRANSPLANTATION PROCEEDINGS
- In vitro and in vivo study of epigallocatechin-3-gallate-induced apoptosis in aerobic glycolytic hepatocellular carcinoma cells involving inhibition of phosphofructokinase activity
- (2016) Sainan Li et al. Scientific Reports
- The Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant Disease
- (2016) Tina J. Hieken et al. Scientific Reports
- Bile acid signaling and liver regeneration
- (2015) Mingjie Fan et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- MafG, A Novel Target of FXR that Regulates Bile Acid Homeostasis
- (2015) Yoon Mee Yang et al. GASTROENTEROLOGY
- Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells
- (2015) Jialin He et al. Molecular Cancer
- The G-protein-coupled bile acid receptor Gpbar1 (TGR5) suppresses gastric cancer cell proliferation and migration through antagonizing STAT3 signaling pathway
- (2015) Cong Guo et al. Oncotarget
- Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism
- (2015) Eric Kwong et al. Acta Pharmaceutica Sinica B
- The Bacteroides fragilis Toxin Gene Is Prevalent in the Colon Mucosa of Colorectal Cancer Patients
- (2014) Annemarie Boleij et al. CLINICAL INFECTIOUS DISEASES
- Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer
- (2014) Jessica Tsuei et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Secondary bile acids: an underrecognized cause of colon cancer
- (2014) Hana Ajouz et al. World Journal of Surgical Oncology
- The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update
- (2014) Ming Liu et al. Protein & Cell
- Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
- (2013) Sama I. Sayin et al. Cell Metabolism
- Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
- (2013) Shin Yoshimoto et al. NATURE
- Fusobacterium Is Associated with Colorectal Adenomas
- (2013) Amber N. McCoy et al. PLoS One
- Bile acids increase alveolar epithelial permeability via mitogen-activated protein kinase, cytosolic phospholipase A2, cyclooxygenase-2, prostaglandin E2and junctional proteins
- (2013) Kang-Cheng Su et al. RESPIROLOGY
- Small heterodimer partner overexpression partially protects against liver tumor development in farnesoid X receptor knockout mice
- (2013) Guodong Li et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Bile Acids Activate YAP to Promote Liver Carcinogenesis
- (2013) Sayeepriyadarshini Anakk et al. Cell Reports
- Downregulation of nuclear receptor FXR is associated with multiple malignant clinicopathological characteristics in human hepatocellular carcinoma
- (2012) Hongying Su et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
- (2012) Dianne H. Dapito et al. CANCER CELL
- Promotion of liver regeneration/repair by farnesoid X receptor in both liver and intestine in mice
- (2012) Lisheng Zhang et al. HEPATOLOGY
- Deficiency of G-protein-coupled bile acid receptor Gpbar1 (TGR5) enhances chemically induced liver carcinogenesis
- (2012) Wei-Dong Chen et al. HEPATOLOGY
- Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma
- (2012) Yuan Chen et al. HEPATOLOGY
- Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer
- (2012) Yanjun Jiang et al. HEPATOLOGY
- Critical role of farnesoid X receptor for hepatocellular carcinoma cell proliferation
- (2012) T. Fujino et al. JOURNAL OF BIOCHEMISTRY
- Deletion of IFNγ enhances hepatocarcinogenesis in FXR knockout mice
- (2012) Zhipeng Meng et al. JOURNAL OF HEPATOLOGY
- Activation of Farnesoid X Receptor Increases the Expression of Cytokine Inducible SH2-Containing Protein in HepG2 Cells
- (2012) Zhizhen Xu et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Downregulation of Human Farnesoid X Receptor by miR-421 Promotes Proliferation and Migration of Hepatocellular Carcinoma Cells
- (2012) Y. Zhang et al. MOLECULAR CANCER RESEARCH
- Loss of FXR Protects against Diet-Induced Obesity and Accelerates Liver Carcinogenesis inob/obMice
- (2012) Yanqiao Zhang et al. MOLECULAR ENDOCRINOLOGY
- Hepatocarcinogenesis in FXR−/−Mice Mimics Human HCC Progression That Operates through HNF1α Regulation of FXR Expression
- (2012) Nian Liu et al. MOLECULAR ENDOCRINOLOGY
- No Correlation between the Expression of FXR and Genes Involved in Multidrug Resistance Phenotype of Primary Liver Tumors
- (2012) P. Martinez-Becerra et al. MOLECULAR PHARMACEUTICS
- FXR Controls the Tumor Suppressor NDRG2 and FXR Agonists Reduce Liver Tumor Growth and Metastasis in an Orthotopic Mouse Xenograft Model
- (2012) Ulrich Deuschle et al. PLoS One
- Signaling pathway/molecular targets and new targeted agents under development in hepatocellular carcinoma
- (2012) Masatoshi Kudo WORLD JOURNAL OF GASTROENTEROLOGY
- The G-Protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-κB) in mice
- (2011) Yan-Dong Wang et al. HEPATOLOGY
- Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2 −/− (Abcb4 −/− ) mouse cholangiopathy model by promoting biliary HCO 3− output
- (2011) Anna Baghdasaryan et al. HEPATOLOGY
- Increased Activation of the Wnt/ -Catenin Pathway in Spontaneous Hepatocellular Carcinoma Observed in Farnesoid X Receptor Knockout Mice
- (2011) A. Wolfe et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The Bile Acid Receptor GPBAR-1 (TGR5) Modulates Integrity of Intestinal Barrier and Immune Response to Experimental Colitis
- (2011) Sabrina Cipriani et al. PLoS One
- The membrane-bound bile acid receptor TGR5 (Gpbar-1) is localized in the primary cilium of cholangiocytes
- (2010) Verena Keitel et al. BIOLOGICAL CHEMISTRY
- Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents
- (2010) Le-Xing Yu et al. HEPATOLOGY
- FXR Regulates Liver Repair after CCl4-Induced Toxic Injury
- (2010) Zhipeng Meng et al. MOLECULAR ENDOCRINOLOGY
- Hepatocellular carcinoma: a global view
- (2010) Ju Dong Yang et al. Nature Reviews Gastroenterology & Hepatology
- Farnesoid X Receptor Critically Determines the Fibrotic Response in Mice but Is Expressed to a Low Extent in Human Hepatic Stellate Cells and Periductal Myofibroblasts
- (2009) Peter Fickert et al. AMERICAN JOURNAL OF PATHOLOGY
- Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064
- (2009) Pilar Martínez-Fernández et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens
- (2009) J G Fox et al. GUT
- The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders
- (2009) Verena Keitel et al. HEPATOLOGY
- Bile acids: regulation of synthesis
- (2009) John Y. L. Chiang JOURNAL OF LIPID RESEARCH
- Epigenetic Inhibition of Nuclear Receptor Small Heterodimer Partner Is Associated With and Regulates Hepatocellular Carcinoma Growth
- (2008) Nan He et al. GASTROENTEROLOGY
- Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response
- (2008) Yan-Dong Wang et al. HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now